How long does Humalog last in the body?

Humalog starts working within about 15 minutes, peaks between 1 and 2 hours after injection, and lasts roughly 3 to 5 hours. Duration can be slightly longer in people with higher doses or slower absorption. Because it clears quickly, Humalog covers one meal and does not provide basal (background) insulin coverage.

Can I take Humalog after eating instead of before?

Yes, the FDA label allows dosing within 15 minutes before or immediately after a meal. Post-meal dosing may be preferred for young children or people with unpredictable appetites, though pre-meal dosing usually gives better control of post-meal glucose spikes. Discuss timing with your diabetes care team.

What is the difference between Humalog and the authorized generic Insulin Lispro?

Insulin Lispro is the same molecule as Humalog, made by Eli Lilly, and sold at roughly half the list price. Clinical effect is identical. Patients who use Humalog can usually switch to Insulin Lispro with their clinician's guidance to reduce cost. Coverage and copays vary by insurance plan.

How should Humalog be stored?

Unopened Humalog vials, pens, and cartridges should be refrigerated between 36 and 46 degrees Fahrenheit until the printed expiration date. Once in use, Humalog can be kept at room temperature (below 86 degrees) for up to 28 days. Never freeze insulin or expose it to direct sunlight or heat.

Humalog Insulin: How It Works, Dosing, and What to Expect

Humalog is a brand of rapid-acting insulin lispro used to control blood sugar spikes at mealtimes in people with type 1 and type 2 diabetes. It starts working within 15 minutes, peaks at about 1 to 2 hours, and lasts 3 to 5 hours. Humalog is usually combined with a longer-acting basal insulin or used in an insulin pump.

How Humalog Works

Insulin lispro is a genetically engineered analog of human insulin. Two amino acids near the end of the insulin B chain are reversed, which prevents the insulin molecules from clumping into hexamers under the skin. The drug absorbs more quickly than regular human insulin and better matches the post-meal glucose surge.

When injected, Humalog binds insulin receptors on muscle, fat, and liver cells, driving glucose into tissues and suppressing hepatic glucose output. The result is a lower rise in blood sugar after eating. Humalog alone does not provide the steady background insulin needed between meals — that is the job of basal insulins such as glargine, detemir, or degludec. For a broader look at how insulin fits within diabetes care, see our treatment overview.

Who Uses Humalog

Humalog is FDA-approved for adults and children with type 1 diabetes, for adults with type 2 diabetes who need mealtime coverage, and for use in insulin pumps. It is typically started when:

A person with type 1 diabetes begins multiple daily injection therapy
A person with type 2 diabetes has rising A1C despite basal insulin and oral medications
Post-meal glucose readings stay above 180 mg/dL on current therapy
An insulin pump requires a rapid-acting analog

Onset, Peak, and Duration

Knowing a drug’s time profile is essential for safe insulin use. The table below compares Humalog to regular human insulin and the newer ultra-rapid options.

Insulin	Onset	Peak	Duration
Humalog (lispro)	10 to 15 min	1 to 2 hr	3 to 5 hr
Regular human insulin (Humulin R, Novolin R)	30 to 60 min	2 to 4 hr	5 to 8 hr
Lyumjev (ultra-rapid lispro)	1 to 3 min	~1 hr	4 to 5 hr
Fiasp (ultra-rapid aspart)	2 to 4 min	~1 hr	3 to 5 hr

How Humalog Is Dosed

There is no single “correct” Humalog dose. Your endocrinologist or diabetes educator calculates a starting plan and adjusts it based on glucose logs. Three numbers drive most mealtime dosing:

Insulin-to-carb ratio: how many grams of carbohydrate one unit of Humalog covers (often 1:10 to 1:15 for adults)
Correction factor (sensitivity): how many mg/dL one unit lowers your blood glucose (often 1:30 to 1:50)
Target glucose: the pre-meal goal, usually 80 to 130 mg/dL

A typical mealtime dose formula is: (grams of carbs ÷ carb ratio) + ((current glucose − target) ÷ correction factor). These numbers are individualized and change with activity, illness, and growth. Never copy another person’s ratios.

Injection Technique and Site Rotation

Humalog is injected into the fatty layer under the skin, most commonly in the abdomen (fastest absorption), upper arm, thigh, or buttock. Rotate within a region from injection to injection to avoid lipohypertrophy — lumpy thickened tissue that can make insulin absorption erratic. Pen needles of 4 mm or 5 mm are enough for most adults and children.

If you use a Humalog KwikPen, perform a 2-unit safety check with each new pen to clear air from the needle. Prime a new vial by drawing back and expelling a small amount before use. Count slowly to 10 before withdrawing the needle to ensure the full dose is delivered.

Common Side Effects

The most frequent side effects of Humalog are predictable consequences of lowering blood sugar or injecting a protein under the skin:

Hypoglycemia — the main risk; symptoms include shakiness, sweating, confusion, and hunger
Weight gain of a few pounds when starting insulin
Injection site reactions — redness, itching, or mild swelling
Lipohypertrophy or lipoatrophy with repeated use of the same spot
Fluid retention when combined with a thiazolidinedione

Serious Warnings

The FDA label for Humalog contains several boxed-level and important warnings.

Severe Hypoglycemia

Very low blood sugar can be life threatening. Rapid-acting insulins are more likely to cause early post-meal lows if the meal is delayed, smaller than expected, or skipped. Carry glucose tablets or gel at all times and teach family members how to use glucagon.

Hypokalemia

Insulin shifts potassium into cells and can lower serum potassium. People with existing hypokalemia, on potassium-wasting diuretics, or who have kidney disease need closer electrolyte monitoring.

Hypersensitivity Reactions

Rare severe allergic reactions including anaphylaxis have occurred. Stop Humalog and seek emergency care for widespread rash, swelling of the face, or trouble breathing.

Drug Interactions

Beta-blockers can mask early symptoms of hypoglycemia. Thiazolidinediones (pioglitazone, rosiglitazone) combined with insulin raise heart failure risk. Corticosteroids, atypical antipsychotics, and high-dose thiazide diuretics can blunt insulin effect and require higher doses.

Humalog Formulations and Delivery Options

Humalog is sold in several presentations so the same insulin can match different lifestyles.

Product	Concentration	Delivery	Typical Use
Humalog U-100 vial	100 units/mL	Syringe or pump	Most adults and children
Humalog KwikPen U-100	100 units/mL	Prefilled disposable pen	Daily injection therapy
Humalog U-200 KwikPen	200 units/mL	Prefilled pen	High-dose users (same volume, half the liquid)
Humalog Junior KwikPen	100 units/mL, 0.5-unit increments	Prefilled pen	Pediatric and insulin-sensitive patients
Insulin Lispro (authorized generic)	100 units/mL	Vial or KwikPen	Cost-conscious patients

Humalog in Pregnancy and Breastfeeding

Insulin lispro has decades of real-world use in pregnancy and is generally considered safe. The American Diabetes Association supports rapid-acting analogs during pregnancy because they improve post-meal control with less hypoglycemia than regular insulin. Insulin does not pass into breast milk in meaningful amounts. Dose needs usually fall in the first trimester and rise substantially in the third.

Cost, Access, and Affordability Programs

The list price of Humalog has drawn criticism for more than a decade. Several paths can lower out-of-pocket cost:

Authorized generic Insulin Lispro — roughly half the Humalog list price
Lilly Insulin Value Program — caps Humalog at $35 per month for most patients
Medicare Part D — $35-per-month cap on covered insulins under the Inflation Reduction Act
Patient assistance programs for qualifying uninsured patients
State insulin affordability laws that cap copays in many states

Monitoring and A1C Goals

The ADA recommends an A1C below 7 percent for most non-pregnant adults, with individualized targets for older adults or those with limited life expectancy. Your team will look at pre-meal, post-meal, and overnight glucose — and increasingly at time-in-range from a continuous glucose monitor — to fine-tune Humalog doses. Keep a logbook of meals, doses, and activity for the first few months of therapy; patterns emerge that no single meter reading reveals.

For background on how these numbers relate to long-term risk, see the A1C levels guide.

When to Contact Your Care Team

Call your diabetes team promptly for any of the following:

Severe hypoglycemia requiring help from another person
Two or more readings above 250 mg/dL in a day
Ketones in urine or vomiting that prevents eating
Sick days or surgery planning — insulin needs change
Injection site that stays red, warm, or painful
Suspected allergic reaction

The Bottom Line

Humalog is one of the most widely used mealtime insulins in the world, with a fast onset, short duration, and decades of clinical experience. Used correctly alongside basal insulin, carb counting, and frequent glucose monitoring, it gives tight control of post-meal spikes in type 1 and type 2 diabetes. The tradeoff is real hypoglycemia risk, so education, site rotation, and regular follow-up with your care team are essential. Ask your clinician whether Humalog or the lower-cost Insulin Lispro fits your plan — clinically they are the same medication.